With the rising demand for high-efficacy skincare and medical aesthetic products, Panlabs Biologics Inc. is leveraging its three core technology platforms—Recombinant Proteins, Extracellular Vesicles (EVs), and Lactobacillus-Derived PDRN (Polydeoxyribonucleotide)—to expand its portfolio of functional active ingredients, offering new momentum for Taiwan’s cosmetics and cosmeceutical industries.

Three Core Technologies Powering Cosmetic Applications

1. Recombinant Protein Development Platform

Panlabs has established a comprehensive production platform for recombinant proteins, focusing on the development of the following high-performance bioactive molecules:

• Cytokines: IL-2, IL-4, IL-6, IL-15 – supporting immune regulation and skin repair
• Growth Factors: FGF2, EGF, VEGF165, hGH, IGF-1 – promoting cell regeneration and skin elasticity
• Structural Proteins: Fibronectin and collagen fragments – helping reinforce skin barrier and firmness

2. Lactobacillus-Derived Extracellular Vesicles (EVs)

Using proprietary Lactobacillus cultivation and purification technology, Panlabs has developed stable, microbial-derived extracellular vesicles with potential applications in:

• Post-procedure repair serums
• Injectable formulations and ampoules
• High-concentration delivery serums and sheet masks

3. Lactobacillus-Based PDRN (L-PDRN)

Panlabs produces high-purity, Lactobacillus-origin PDRN with tissue-repairing and high-stability properties, suitable for use in:

• Serums and transdermal delivery systems
• Post-laser hydration and repair treatments
• Medical-grade skincare and prescription cosmetic formulations